ziprasidone mesylate

Generic: ziprasidone mesylate

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ziprasidone mesylate
Generic Name ziprasidone mesylate
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients

ziprasidone mesylate 20 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1564
Product ID 51662-1564_1035b793-4301-3cb4-e063-6294a90a5b1f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211908
Listing Expiration 2026-12-31
Marketing Start 2021-07-17

Pharmacologic Class

Classes
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621564
Hyphenated Format 51662-1564

Supplemental Identifiers

RxCUI
351223
UNII
3X6SAX83JZ

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ziprasidone mesylate (source: ndc)
Generic Name ziprasidone mesylate (source: ndc)
Application Number ANDA211908 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 10 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

51662-1564-3 10 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

ziprasidone mesylate (20 mg/mL)

Linked Drug Pages (1)

ZIPRASIDONE MESYLATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "1035b793-4301-3cb4-e063-6294a90a5b1f", "openfda": {"unii": ["3X6SAX83JZ"], "rxcui": ["351223"], "spl_set_id": ["c75971f8-9640-a6e8-e053-2995a90af654"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "10 POUCH in 1 CASE (51662-1564-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1564-3", "marketing_start_date": "20210717"}], "brand_name": "ZIPRASIDONE MESYLATE", "product_id": "51662-1564_1035b793-4301-3cb4-e063-6294a90a5b1f", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "51662-1564", "generic_name": "ZIPRASIDONE MESYLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZIPRASIDONE MESYLATE", "active_ingredients": [{"name": "ZIPRASIDONE MESYLATE", "strength": "20 mg/mL"}], "application_number": "ANDA211908", "marketing_category": "ANDA", "marketing_start_date": "20210717", "listing_expiration_date": "20261231"}